Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionTAP complex binding

HLA-B HLA-C

1.19e-049372GO:0062061
GeneOntologyMolecularFunctionCD8 receptor binding

HLA-B HLA-C

1.19e-049372GO:0042610
GeneOntologyMolecularFunctionTAP1 binding

HLA-B HLA-C

1.49e-0410372GO:0046978
GeneOntologyMolecularFunctionTAP2 binding

HLA-B HLA-C

1.49e-0410372GO:0046979
GeneOntologyMolecularFunctionTAP binding

HLA-B HLA-C

1.49e-0410372GO:0046977
GeneOntologyMolecularFunctionbeta-2-microglobulin binding

HLA-B HLA-C

2.18e-0412372GO:0030881
GeneOntologyMolecularFunctionquinone binding

SDHD AOC3

4.46e-0417372GO:0048038
GeneOntologyMolecularFunctionnatural killer cell lectin-like receptor binding

HLA-B HLA-C

4.46e-0417372GO:0046703
GeneOntologyMolecularFunctionT cell receptor binding

HLA-B HLA-C

6.22e-0420372GO:0042608
GeneOntologyMolecularFunctioncatalytic activity, acting on a nucleic acid

MYO18A QTRT2 CHD8 CHD7 LARS2 PTRHD1

1.10e-03645376GO:0140640
GeneOntologyMolecularFunctionMHC class I protein binding

HLA-B HLA-C

1.60e-0332372GO:0042288
GeneOntologyMolecularFunctionATP-dependent activity, acting on DNA

MYO18A CHD8 CHD7

1.67e-03127373GO:0008094
GeneOntologyMolecularFunctionATP-dependent chromatin remodeler activity

CHD8 CHD7

2.14e-0337372GO:0140658
GeneOntologyMolecularFunctioncatalytic activity, acting on a tRNA

QTRT2 LARS2 PTRHD1

2.38e-03144373GO:0140101
GeneOntologyMolecularFunctionprotein tyrosine kinase activity

HIPK3 ABL2 ROR2

2.43e-03145373GO:0004713
GeneOntologyMolecularFunction14-3-3 protein binding

HLA-B HLA-C

2.75e-0342372GO:0071889
GeneOntologyMolecularFunctionpeptide antigen binding

HLA-B HLA-C

3.72e-0349372GO:0042605
GeneOntologyBiologicalProcessDN4 thymocyte differentiation

ABL2 NFATC3

1.67e-054352GO:1904157
GeneOntologyBiologicalProcessinner ear development

POU4F3 CHD7 HLA-B HLA-C ROR2

6.41e-05253355GO:0048839
GeneOntologyBiologicalProcessantigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent

HLA-B HLA-C

7.78e-058352GO:0002485
GeneOntologyBiologicalProcesstransforming growth factor beta receptor superfamily signaling pathway

SPRY1 TSC22D1 NEO1 SIN3A ROR2 RNF111

9.31e-05445356GO:0141091
GeneOntologyBiologicalProcessear development

POU4F3 CHD7 HLA-B HLA-C ROR2

1.12e-04285355GO:0043583
GeneOntologyBiologicalProcesscell surface receptor protein serine/threonine kinase signaling pathway

SPRY1 TSC22D1 NEO1 SIN3A ROR2 RNF111

1.44e-04482356GO:0007178
GeneOntologyBiologicalProcesssensory organ development

SPRY1 POU4F3 CHD7 GRIN2B HLA-B HLA-C ROR2

1.91e-04730357GO:0007423
GeneOntologyBiologicalProcessauditory behavior

ABL2 NRXN2

2.51e-0414352GO:0031223
GeneOntologyBiologicalProcessregulation of transmembrane receptor protein serine/threonine kinase signaling pathway

SPRY1 TSC22D1 NEO1 SIN3A RNF111

2.81e-04347355GO:0090092
GeneOntologyBiologicalProcessregulation of transforming growth factor beta receptor signaling pathway

SPRY1 TSC22D1 SIN3A RNF111

3.04e-04192354GO:0017015
GeneOntologyBiologicalProcessregulation of cellular response to transforming growth factor beta stimulus

SPRY1 TSC22D1 SIN3A RNF111

3.22e-04195354GO:1903844
GeneOntologyBiologicalProcessantigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent

HLA-B HLA-C

3.31e-0416352GO:0002486
GeneOntologyBiologicalProcessantigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway

HLA-B HLA-C

3.74e-0417352GO:0002484
GeneOntologyBiologicalProcessantigen processing and presentation of endogenous peptide antigen via MHC class Ib

HLA-B HLA-C

3.74e-0417352GO:0002476
GeneOntologyBiologicalProcessmechanosensory behavior

ABL2 NRXN2

3.74e-0417352GO:0007638
GeneOntologyBiologicalProcessantigen processing and presentation of peptide antigen via MHC class Ib

HLA-B HLA-C

4.21e-0418352GO:0002428
GeneOntologyBiologicalProcessantigen processing and presentation of exogenous peptide antigen via MHC class I

HLA-B HLA-C

4.21e-0418352GO:0042590
GeneOntologyBiologicalProcessregulation of plasma membrane bounded cell projection organization

NEO1 GRIN2B ABL2 CDC20 HLA-B HLA-C ROR2

4.68e-04846357GO:0120035
GeneOntologyBiologicalProcessregulation of neuron projection development

NEO1 ABL2 CDC20 HLA-B HLA-C ROR2

5.19e-04612356GO:0010975
GeneOntologyBiologicalProcessregulation of cell projection organization

NEO1 GRIN2B ABL2 CDC20 HLA-B HLA-C ROR2

5.28e-04863357GO:0031344
GeneOntologyBiologicalProcessneuromuscular process

CHD8 POU4F3 GRIN2B ABL2

5.54e-04225354GO:0050905
GeneOntologyBiologicalProcessexport from cell

MYO18A CHD7 NEO1 GRIN2B NRXN2 SLC30A4 SLC47A2 SDHD

5.66e-041153358GO:0140352
GeneOntologyBiologicalProcessregulation of cellular response to growth factor stimulus

SPRY1 TSC22D1 NEO1 SIN3A RNF111

6.15e-04412355GO:0090287
GeneOntologyBiologicalProcessnegative regulation of cell projection organization

NEO1 GRIN2B HLA-B HLA-C

6.31e-04233354GO:0031345
GeneOntologyBiologicalProcessantigen processing and presentation of endogenous peptide antigen via MHC class I

HLA-B HLA-C

6.92e-0423352GO:0019885
GeneOntologyBiologicalProcesschordate embryonic development

NCOR2 CHD8 CHD7 SIN3A GRIN2B ABL2 ROR2

7.05e-04906357GO:0043009
GeneOntologyBiologicalProcessdevelopmental growth

SPRY1 POU4F3 CHD7 SIN3A ABL2 HLA-B HLA-C

7.28e-04911357GO:0048589
GeneOntologyBiologicalProcessmulticellular organism growth

CHD7 ABL2 HLA-B HLA-C

8.09e-04249354GO:0035264
GeneOntologyBiologicalProcessembryo development ending in birth or egg hatching

NCOR2 CHD8 CHD7 SIN3A GRIN2B ABL2 ROR2

8.17e-04929357GO:0009792
GeneOntologyBiologicalProcessantigen processing and presentation of endogenous peptide antigen

HLA-B HLA-C

8.19e-0425352GO:0002483
GeneOntologyBiologicalProcessantigen processing and presentation via MHC class Ib

HLA-B HLA-C

8.19e-0425352GO:0002475
GeneOntologyBiologicalProcessgrowth

SPRY1 POU4F3 CHD7 SIN3A ABL2 HLA-B HLA-C PRDM4

8.90e-041235358GO:0040007
GeneOntologyBiologicalProcesspositive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway

TSC22D1 NEO1 RNF111

9.70e-04115353GO:0090100
GeneOntologyBiologicalProcessneuron projection development

POU4F3 NEO1 SIN3A ABL2 CDC20 HLA-B HLA-C ROR2

1.15e-031285358GO:0031175
GeneOntologyBiologicalProcessdendritic spine maintenance

GRIN2B ABL2

1.18e-0330352GO:0097062
GeneOntologyBiologicalProcesstransforming growth factor beta receptor signaling pathway

SPRY1 TSC22D1 SIN3A RNF111

1.18e-03276354GO:0007179
GeneOntologyBiologicalProcessnegative regulation of miRNA transcription

NCOR2 NFATC3

1.26e-0331352GO:1902894
GeneOntologyBiologicalProcessprotein heterooligomerization

ZNF777 GRIN2B

1.26e-0331352GO:0051291
GeneOntologyBiologicalProcessantigen processing and presentation of endogenous antigen

HLA-B HLA-C

1.34e-0332352GO:0019883
GeneOntologyBiologicalProcessinner ear morphogenesis

POU4F3 CHD7 ROR2

1.35e-03129353GO:0042472
GeneOntologyCellularComponentMHC class Ib protein complex

HLA-B HLA-C

5.69e-057352GO:0032398
GeneOntologyCellularComponentMHC class I protein complex

HLA-B HLA-C

1.22e-0410352GO:0042612
GeneOntologyCellularComponentMHC class I peptide loading complex

HLA-B HLA-C

2.45e-0414352GO:0042824
GeneOntologyCellularComponentcis-Golgi network membrane

HLA-B HLA-C

3.65e-0417352GO:0033106
GeneOntologyCellularComponentGolgi medial cisterna

HLA-B HLA-C

6.74e-0423352GO:0005797
GeneOntologyCellularComponentmethyltransferase complex

CHD8 PRDM4 ZC3H13

7.78e-04108353GO:0034708
GeneOntologyCellularComponentMHC protein complex

HLA-B HLA-C

8.63e-0426352GO:0042611
GeneOntologyCellularComponentlumenal side of endoplasmic reticulum membrane

HLA-B HLA-C

1.57e-0335352GO:0098553
GeneOntologyCellularComponentcell surface

MYO18A NEO1 GRIN2B HLA-B HLA-C ROR2 AOC3

2.13e-031111357GO:0009986
GeneOntologyCellularComponentendoplasmic reticulum exit site

HLA-B HLA-C

2.25e-0342352GO:0070971
GeneOntologyCellularComponentphagocytic vesicle

MYO18A HLA-B HLA-C

2.28e-03157353GO:0045335
GeneOntologyCellularComponentlumenal side of membrane

HLA-B HLA-C

2.93e-0348352GO:0098576
MousePhenodecreased startle reflex

HIPK3 CHD8 POU4F3 CHD7 ABL2

5.05e-05224265MP:0001489
MousePhenoabnormal startle reflex

HIPK3 CHD8 POU4F3 CHD7 GRIN2B ABL2 NFATC3

7.59e-05591267MP:0001486
MousePhenospinal cord inflammation

HLA-B HLA-C

9.25e-058262MP:0030987
MousePhenoperiorbital edema

CHD7 NFATC3

9.25e-058262MP:0001788
MousePhenoabnormal periorbital region morphology

CHD7 NFATC3

1.48e-0410262MP:0030038
MousePhenoabnormal crista ampullaris neuroepithelium morphology

POU4F3 CHD7

1.81e-0411262MP:0004409
DomainBRK

CHD8 CHD7

5.39e-056362SM00592
DomainMHC_I_C

HLA-B HLA-C

5.39e-056362PF06623
DomainBRK_domain

CHD8 CHD7

5.39e-056362IPR006576
DomainMHC_I_a_C

HLA-B HLA-C

5.39e-056362IPR010579
DomainBRK

CHD8 CHD7

5.39e-056362PF07533
DomainMHC_I

HLA-B HLA-C

7.41e-0421362PF00129
DomainMHC_I_a_a1/a2

HLA-B HLA-C

7.41e-0421362IPR001039
DomainChromo_domain

CHD8 CHD7

9.71e-0424362IPR023780
Domain-

HLA-B HLA-C

9.71e-04243623.30.500.10
DomainMHC_I-like_Ag-recog

HLA-B HLA-C

9.71e-0424362IPR011161
DomainChromo

CHD8 CHD7

1.14e-0326362PF00385
DomainCHROMO_2

CHD8 CHD7

1.32e-0328362PS50013
DomainCHROMO_1

CHD8 CHD7

1.32e-0328362PS00598
DomainSNF2_N

CHD8 CHD7

1.73e-0332362PF00176
DomainSNF2_N

CHD8 CHD7

1.73e-0332362IPR000330
DomainChromodomain-like

CHD8 CHD7

1.73e-0332362IPR016197
DomainCHROMO

CHD8 CHD7

1.84e-0333362SM00298
DomainChromo/shadow_dom

CHD8 CHD7

1.84e-0333362IPR000953
DomainDNA/RNA_helicase_DEAH_CS

CHD8 CHD7

2.07e-0335362IPR002464
DomainDEAH_ATP_HELICASE

CHD8 CHD7

2.43e-0338362PS00690
DomainMHC_I/II-like_Ag-recog

HLA-B HLA-C

2.43e-0338362IPR011162
DomainSANT

NCOR2 CHD7

4.18e-0350362SM00717
DomainSANT/Myb

NCOR2 CHD7

4.51e-0352362IPR001005
DomainC1-set

HLA-B HLA-C

4.85e-0354362PF07654
DomainIGc1

HLA-B HLA-C

5.21e-0356362SM00407
DomainIg_C1-set

HLA-B HLA-C

5.58e-0358362IPR003597
DomainIg/MHC_CS

HLA-B HLA-C

5.58e-0358362IPR003006
DomainIG_MHC

HLA-B HLA-C

5.96e-0360362PS00290
Domain-

NEO1 HLA-B HLA-C NFATC3 ROR2

8.42e-036633652.60.40.10
DomainIg-like_fold

NEO1 HLA-B HLA-C NFATC3 ROR2

1.09e-02706365IPR013783
PathwayKEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES

HLA-B HLA-C

6.10e-056292M47468
PathwayKEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES

HLA-B HLA-C

8.53e-057292M47582
PathwayKEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES

HLA-B HLA-C

8.53e-057292M47530
PathwayREACTOME_ENDOSOMAL_VACUOLAR_PATHWAY

HLA-B HLA-C

1.46e-049292MM14527
PathwayKEGG_CELL_ADHESION_MOLECULES_CAMS

NEO1 HLA-B NRXN2 HLA-C

1.50e-04133294M16476
PathwayREACTOME_ENDOSOMAL_VACUOLAR_PATHWAY

HLA-B HLA-C

2.22e-0411292M525
PathwayKEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES

HLA-B HLA-C

2.66e-0412292M47529
PathwayREACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2

NCOR2 SIN3A GRIN2B

2.86e-0463293M27862
PathwayREACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME

NCOR2 SIN3A

3.14e-0413292M29766
PathwayKEGG_VIRAL_MYOCARDITIS

ABL2 HLA-B HLA-C

3.91e-0470293M12294
PathwayBIOCARTA_ETS_PATHWAY

NCOR2 SIN3A

5.45e-0417292M14449
PathwayBIOCARTA_ETS_PATHWAY

NCOR2 SIN3A

5.45e-0417292MM1435
PathwayREACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA

NCOR2 SIN3A

6.13e-0418292MM15034
PathwayREACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS

SIN3A GRIN2B

6.13e-0418292M27901
PathwayREACTOME_ER_PHAGOSOME_PATHWAY

HLA-B HLA-C

6.13e-0418292MM14525
PathwayBIOCARTA_CTL_PATHWAY

HLA-B HLA-C

7.59e-0420292MM1374
PathwayWP_AMINO_ACID_METABOLISM

LARS2 SDHD AOC3

1.04e-0398293MM15942
PathwayBIOCARTA_NKCELLS_PATHWAY

HLA-B HLA-C

1.19e-0325292MM1465
PathwayREACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC

HLA-B HLA-C

1.19e-0325292MM15713
PathwayWP_WNT_SIGNALING_WP428

CHD8 NFATC3 ROR2

1.57e-03113293M39669
PathwayREACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC

HLA-B HLA-C

1.60e-0329292M1062
PathwayREACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY

NCOR2 RNF111

1.83e-0331292M669
PathwayPID_WNT_NONCANONICAL_PATHWAY

CHD7 ROR2

1.95e-0332292M23
PathwayREACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY

NCOR2 SIN3A

1.95e-0332292M27900
PathwayWP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV

GRIN2B NRXN2

2.07e-0333292M39875
Pubmed

A human MAP kinase interactome.

MYO18A HIPK3 CHD8 TSC22D1 ABL2 HLA-B RNF111

7.14e-0748637720936779
Pubmed

Two new HLA class I alleles recognised by PCR sequence-specific primer and sequencing based typing: B*3805 and Cw*0408.

HLA-B HLA-C

1.10e-06237211972879
Pubmed

Identification of a novel HLA-Cw*05 allele, Cw*0503.

HLA-B HLA-C

1.10e-06237210885573
Pubmed

MHC-driven HIV-1 control on the long run is not systematically determined at early times post-HIV-1 infection.

HLA-B HLA-C

1.10e-06237223462218
Pubmed

Distinct clinical differences between HLA-Cw*0602 positive and negative psoriasis patients--an analysis of 1019 HLA-C- and HLA-B-typed patients.

HLA-B HLA-C

1.10e-06237216439971
Pubmed

Complete sequence of HLA-B27 cDNA identified through the characterization of structural markers unique to the HLA-A, -B, and -C allelic series.

HLA-B HLA-C

1.10e-0623723485286
Pubmed

Sequence of four new HLA-Cw alleles: a possible role of interallelic recombination.

HLA-B HLA-C

1.10e-0623729459506
Pubmed

A reliable and efficient high resolution typing method for HLA-C using sequence-based typing.

HLA-B HLA-C

1.10e-0623729894855
Pubmed

Effect of missing killer-immunoglobulin-like receptor ligand in recipients undergoing HLA full matched, non-T-depleted sibling donor transplantation: a single institution experience of 151 Asian patients.

HLA-B HLA-C

1.10e-06237219898503
Pubmed

Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls.

HLA-B HLA-C

1.10e-06237223935489
Pubmed

Differential human leucocyte allele association between psoriasis and psoriatic arthritis: a family-based association study.

HLA-B HLA-C

1.10e-06237222586163
Pubmed

Comparison of MHC class I risk haplotypes in Thai and Caucasian psoriatics shows locus heterogeneity at PSORS1.

HLA-B HLA-C

1.10e-06237220604894
Pubmed

Protective Effect of HLA-B*5701 and HLA-C -35 Genetic Variants in HIV-Positive Caucasians from Northern Poland.

HLA-B HLA-C

1.10e-06237226068923
Pubmed

An HLA-C amino-acid variant in addition to HLA-B*27 confers risk for ankylosing spondylitis in the Korean population.

HLA-B HLA-C

1.10e-06237226613595
Pubmed

Distribution of the HLA class I allele in chronic hepatitis C and its association with serum ALT level in chronic hepatitis C.

HLA-B HLA-C

1.10e-06237214626512
Pubmed

A novel and major association of HLA-C in Graves' disease that eclipses the classical HLA-DRB1 effect.

HLA-B HLA-C

1.10e-06237217597093
Pubmed

HLA class I alleles of LCL 721 and 174 x CEM.T2 (T2).

HLA-B HLA-C

1.10e-0623727871529
Pubmed

Associations between MHC class I and susceptibility to HIV-2 disease progression.

HLA-B HLA-C

1.10e-06237212352262
Pubmed

Central role of reverting mutations in HLA associations with human immunodeficiency virus set point.

HLA-B HLA-C

1.10e-06237218596105
Pubmed

CHD8 interacts with CHD7, a protein which is mutated in CHARGE syndrome.

CHD8 CHD7

1.10e-06237220453063
Pubmed

Distribution of HLA-B*27 subtypes in Tunisians and their association with ankylosing spondylitis.

HLA-B HLA-C

1.10e-06237218329312
Pubmed

Association between HLA-B*44:03-HLA-C*07:01 haplotype and cold medicine-related Stevens-Johnson syndrome with severe ocular complications in Thailand.

HLA-B HLA-C

1.10e-06237229706602
Pubmed

The association and differentiation of MHC class I polymorphic Alu insertions and HLA-B/Cw alleles in seven Chinese populations.

HLA-B HLA-C

1.10e-06237220492592
Pubmed

Haplotypic association of two new HLA class I alleles: Cw*15052 and B*0706: evolutionary relationships of HLA-Cw*15 alleles.

HLA-B HLA-C

1.10e-0623728773323
Pubmed

The Association Between HLA Genetic Susceptibility Markers and Sonographic Enthesitis in Psoriatic Arthritis.

HLA-B HLA-C

1.10e-06237229361203
Pubmed

New insights of HLA class I association to Behçet's disease in Portuguese patients.

HLA-B HLA-C

1.10e-06237218627572
Pubmed

Identification of three new HLA class I alleles: HLA-B*50:73, -C*08:218 and -C*15:229.

HLA-B HLA-C

1.10e-06237233227170
Pubmed

HLA-B and C Expression Contributes to COVID-19 Disease Severity within a South African Cohort.

HLA-B HLA-C

1.10e-06237238674456
Pubmed

Implications of the diversity of class I HLA associations in psoriatic arthritis.

HLA-B HLA-C

1.10e-06237227455857
Pubmed

Immunogenetic factors in early immune control of human immunodeficiency virus type 1 (HIV-1) infection: Evaluation of HLA class I amino acid variants in two African populations.

HLA-B HLA-C

1.10e-06237229289742
Pubmed

Diversity of HLA-B17 alleles and haplotypes in East Asians and a novel Cw6 allele (Cw*0604) associated with B*5701.

HLA-B HLA-C

1.10e-06237210395103
Pubmed

HLA-B and HLA-C alleles and haplotypes in the Dravidian tribal populations of southern India.

HLA-B HLA-C

1.10e-06237215191523
Pubmed

Colorectal carcinomas with CpG island methylator phenotype 1 frequently contain mutations in chromatin regulators.

CHD8 CHD7

1.10e-06237224211491
Pubmed

The contribution of HLA class I antigens in immune status following two doses of rubella vaccination.

HLA-B HLA-C

1.10e-06237215603879
Pubmed

There is more to HLA-C than exons 2 and 3: sequencing exons 1, 4 and 5.

HLA-B HLA-C

1.10e-06237210488744
Pubmed

Two new HLA alleles, HLA-B*18:200 and HLA-C*04:435 detected in Russian donors.

HLA-B HLA-C

1.10e-06237233306271
Pubmed

Differences in intron 2 sequences between B*39061 and B*39062 in Amerindians: comparison with those of B*3901, B*5101, and B*52012 alleles.

HLA-B HLA-C

1.10e-0623729089103
Pubmed

The phylogenies of introns 4-7 demonstrate an inconsistent pattern between human leukocyte antigen-C group topologies.

HLA-B HLA-C

1.10e-06237214705982
Pubmed

Epstein-Barr virus negativity among individuals older than 60 years is associated with HLA-C and HLA-Bw4 variants and tonsillectomy.

HLA-B HLA-C

1.10e-06237223536655
Pubmed

Associations of HLA-C*01:02 and HLA-B*46:01 with regorafenib-induced erythema multiforme in Japanese patients with metastatic colorectal cancer.

HLA-B HLA-C

1.10e-06237237424405
Pubmed

Sequence-based typing provides a new look at HLA-C diversity.

HLA-B HLA-C

1.10e-0623729686604
Pubmed

HLA-B*44 and C*01 Prevalence Correlates with Covid19 Spreading across Italy.

HLA-B HLA-C

1.10e-06237232717807
Pubmed

Analysis for complete genomic sequence of HLA-B and HLA-C alleles in the Chinese Han population.

HLA-B HLA-C

1.10e-06237221585707
Pubmed

The novel HLA-Cw*1802 allele is associated with B*5703 in the Bubi population from Equatorial Guinea.

HLA-B HLA-C

1.10e-0623729234488
Pubmed

Association of HLA B*3520, B*1801, and Cw*1507 with HIV-1 infection Maharashtra, India.

HLA-B HLA-C

1.10e-06237214501803
Pubmed

Fine mapping of the psoriasis susceptibility gene PSORS1: a reassessment of risk associated with a putative risk haplotype lacking HLA-Cw6.

HLA-B HLA-C

1.10e-06237215854032
Pubmed

HLA polymorphism among Chinese patients with chronic plaque psoriasis: subgroup analysis.

HLA-B HLA-C

1.10e-06237221985130
Pubmed

Combined effects of HLA-Cw6 and cigarette smoking in psoriasis vulgaris: a hospital-based case-control study in China.

HLA-B HLA-C

1.10e-06237218702622
Pubmed

HLA Alleles B*53:01 and C*06:02 Are Associated With Higher Risk of P. falciparum Parasitemia in a Cohort in Uganda.

HLA-B HLA-C

1.10e-06237233815410
Pubmed

High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.

HLA-B HLA-C

1.10e-06237226768690
Pubmed

Isolation and characterization of yeast artificial chromosome clones linking the HLA-B and HLA-C loci.

HLA-B HLA-C

1.10e-0623722000377
Pubmed

HLA alleles in pre-menopausal breast cancer patients from western India.

HLA-B HLA-C

1.10e-06237217085834
Pubmed

Clinical and genetic aspects of psoriatic arthritis "sine psoriasis".

HLA-B HLA-C

1.10e-06237214719207
Pubmed

Associations between HLA class I alleles and the prevalence of nasopharyngeal carcinoma (NPC) among Tunisians.

HLA-B HLA-C

1.10e-06237217480220
Pubmed

HLA-B alleles associated with the B15 serologically defined antigens.

HLA-B HLA-C

1.10e-0623729455497
Pubmed

A whole-genome association study of major determinants for host control of HIV-1.

HLA-B HLA-C

1.10e-06237217641165
Pubmed

Specific associations of fluorescent beta-2-microglobulin with cell surfaces. The affinity of different H-2 and HLA antigens for beta-2-microglobulin.

HLA-B HLA-C

3.30e-0633722450918
Pubmed

Distributions of HLA class I alleles and haplotypes in Northern Han Chinese.

HLA-B HLA-C

3.30e-06337216185325
Pubmed

Locus-specific constitutive and cytokine-induced HLA class I gene expression.

HLA-B HLA-C

3.30e-06337212574356
Pubmed

Filling the gaps - the generation of full genomic sequences for 15 common and well-documented HLA class I alleles using next-generation sequencing technology.

HLA-B HLA-C

3.30e-06337223246585
Pubmed

Hla-Cw7 allele as predictor of favorable therapeutic response to interferon-alpha in patients with chronic hepatitis C.

HLA-B HLA-C

3.30e-06337218074415
Pubmed

The detailed distribution of HLA-A, B, C antigens in normal human organs.

HLA-B HLA-C

3.30e-0633726591601
Pubmed

Oligodendrocyte precursor survival and differentiation requires chromatin remodeling by Chd7 and Chd8.

CHD8 CHD7

3.30e-06337230108144
Pubmed

HLA-B*07, HLA-DRB1*07, HLA-DRB1*12, and HLA-C*03:02 Strongly Associate With BMI: Data From 1.3 Million Healthy Chinese Adults.

HLA-B HLA-C

3.30e-06337229483183
Pubmed

[Haplotype and linkage analysis of HLA-I classical genes in Chinese Han population].

HLA-B HLA-C

3.30e-06337217956696
Pubmed

Orientation of loci within the human major histocompatibility complex by chromosomal in situ hybridization.

HLA-B HLA-C

3.30e-0633726585830
Pubmed

Targeting HIV-1 Gag into the defective ribosomal product pathway enhances MHC class I antigen presentation and CD8+ T cell activation.

HLA-B HLA-C

3.30e-06337218097038
Pubmed

Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein.

HLA-B HLA-C

3.30e-06337211390610
Pubmed

Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.

HLA-B HLA-C

3.30e-06337211927505
Pubmed

HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions.

HLA-B HLA-C

3.30e-06337219694795
Pubmed

[Association of gene HLA-class I with leukemia].

HLA-B HLA-C

3.30e-06337216129034
Pubmed

[Impact of donor KIR2DS5 genotype on outcome following haploidentical hematopoietic stem cell transplantation].

HLA-B HLA-C

3.30e-06337218315912
Pubmed

Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: results from Sinikithemba Cohort, Durban, South Africa.

HLA-B HLA-C

3.30e-06337219663693
Pubmed

Human Leukocyte Antigen Class I Genes Associated With Stevens-Johnson Syndrome and Severe Ocular Complications Following Use of Cold Medicine in a Brazilian Population.

HLA-B HLA-C

3.30e-06337228278336
Pubmed

Relationship between human leucocyte antigen class I and class II and chronic idiopathic urticaria associated with aspirin and/or NSAIDs hypersensitivity.

HLA-B HLA-C

3.30e-06337217392574
Pubmed

Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responses.

HLA-B HLA-C

3.30e-06337216331510
Pubmed

Persistence of hepatitis C virus in a white population: associations with human leukocyte antigen class 1.

HLA-B HLA-C

3.30e-06337215301865
Pubmed

[Studies of the relationship of HLA polymorphisms and the infection of H. pylori in the population of Linqu in Shandong Province].

HLA-B HLA-C

3.30e-06337215662734
Pubmed

Allelic diversity and haplotype structure of HLA loci in the Chinese Han population living in the Guanzhong region of the Shaanxi province.

HLA-B HLA-C

3.30e-06337220219611
Pubmed

HIV and human leukocyte antigen association--the Indian scenario.

HLA-B HLA-C

3.30e-06337215534563
Pubmed

HLA B*44: protective effects in MS susceptibility and MRI outcome measures.

HLA-B HLA-C

3.30e-06337220713950
Pubmed

Polymorphism of HLA class I genes in the Brazilian population from the Northeastern State of Pernambuco corroborates anthropological evidence of its origin.

HLA-B HLA-C

3.30e-06337215245377
Pubmed

Human leukocyte antigen-A, -B and -C alleles and human leukocyte antigen haplotypes in Turkey: relationship to other populations.

HLA-B HLA-C

3.30e-06337215245373
Pubmed

Transmission of HIV-1 and HLA-B allele-sharing within serodiscordant heterosexual Zambian couples.

HLA-B HLA-C

3.30e-06337215220037
Pubmed

Association of an extended haplotype of HLA class I alleles and their flanking microsatellites with spondyloarthropathies in South Indian patients.

HLA-B HLA-C

3.30e-06337216720212
Pubmed

Impact of HLA-A,B,C allele mismatches on outcome after unrelated blood stem cell transplantation in whites.

HLA-B HLA-C

3.30e-06337215480178
Pubmed

HLA-C(*)03 is a risk factor for cardiomyopathy in Chagas disease.

HLA-B HLA-C

3.30e-06337211053636
Pubmed

HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure.

HLA-B HLA-C

3.30e-06337233968060
Pubmed

Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection.

HLA-B HLA-C

3.30e-06337218580606
Pubmed

The role of HLA class I gene variation in autoimmune diabetes.

HLA-B HLA-C

3.30e-06337217491685
Pubmed

The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection.

HLA-B HLA-C

3.30e-06337211120862
Pubmed

Association of human leukocyte antigen class I antigens in Iranian patients with pemphigus vulgaris.

HLA-B HLA-C

3.30e-06337223330836
Pubmed

Psoriasis regression analysis of MHC loci identifies shared genetic variants with vitiligo.

HLA-B HLA-C

3.30e-06337222125590
Pubmed

HLA-A*02:01:01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients.

HLA-B HLA-C

3.30e-06337225495410
Pubmed

Immune selection in vitro reveals human immunodeficiency virus type 1 Nef sequence motifs important for its immune evasion function in vivo.

HLA-B HLA-C

3.30e-06337222553319
Pubmed

Transcription of preintegrated HIV-1 cDNA modulates cell surface expression of major histocompatibility complex class I via Nef.

HLA-B HLA-C

3.30e-06337221209113
Pubmed

HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load.

HLA-B HLA-C

3.30e-06337218434400
Pubmed

Genetic epidemiology of glioblastoma multiforme: confirmatory and new findings from analyses of human leukocyte antigen alleles and motifs.

HLA-B HLA-C

3.30e-06337219774073
Pubmed

Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.

HLA-B HLA-C

3.30e-06337220574122
Pubmed

Effects of human leukocyte antigen class I genetic parameters on clinical outcomes and survival after initiation of highly active antiretroviral therapy.

HLA-B HLA-C

3.30e-06337217471440
InteractionRGMA interactions

NCOR2 NEO1 PPP1R16A

4.97e-0619363int:RGMA
InteractionHLA-E interactions

HLA-B HLA-C ROR2 PPP1R16A

1.17e-0579364int:HLA-E
InteractionOGFOD3 interactions

HLA-B HLA-C ROR2

2.51e-0532363int:OGFOD3
InteractionPRRG4 interactions

ABL2 HLA-C AOC3

4.58e-0539363int:PRRG4
InteractionSKIL interactions

HIPK3 NCOR2 SIN3A RNF111

5.88e-05119364int:SKIL
GeneFamilyC1-set domain containing

HLA-B HLA-C

1.53e-0342252591
GeneFamilyHistocompatibility complex|C1-set domain containing

HLA-B HLA-C

1.68e-0344252588
GeneFamilyGATA zinc finger domain containing|Myb/SANT domain containing

NCOR2 CHD7

2.42e-0353252532
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

NEO1 ROR2

2.07e-02161252593
CoexpressionRUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP

HIPK3 HLA-B HLA-C

5.83e-0625373MM672
CoexpressionGSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_DN

CHD7 HLA-B HLA-C PRDM4 ROR2

8.17e-06197375M9580
CoexpressionAIZARANI_LIVER_C32_MVECS_3

AFF1 SPRY1 TSC22D1 HLA-B

2.88e-05125374M39131
CoexpressionHU_GENOTOXIC_DAMAGE_4HR

CDC20 HLA-B HLA-C

3.07e-0543373MM1204
CoexpressionTABULA_MURIS_SENIS_LUNG_TYPE_II_PNEUMOCYTE_AGEING

TSC22D1 HLA-B HLA-C

3.30e-0544373MM3775
CoexpressionHOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN

CDC20 HLA-B HLA-C

3.30e-0544373MM805
CoexpressionTABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING

CHD8 GRIN2B HLA-B NRXN2 HLA-C SLC30A4 RELL2 PTRHD1

4.51e-05954378MM3689
CoexpressionTABULA_MURIS_SENIS_TONGUE_BASAL_CELL_OF_EPIDERMIS_AGEING

TSC22D1 CDC20 HLA-B HLA-C

7.19e-05158374MM3851
CoexpressionTABULA_MURIS_SENIS_BRAIN_NON_MYELOID_INTERNEURON_AGEING

HLA-B NRXN2 HLA-C

7.97e-0559373MM3688
CoexpressionGSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_UP

SPRY1 CHD7 HLA-B PRDM4

1.72e-04198374M3198
CoexpressionGSE20366_CD103_KLRG1_DP_VS_DN_TREG_UP

AFF1 SPRY1 ROR2 AOC3

1.75e-04199374M4341
CoexpressionGSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_DN

CHD7 PRDM4 ANKRD55 RNF111

1.78e-04200374M8040
CoexpressionGSE17721_0.5H_VS_4H_CPG_BMDC_UP

MYO18A NCOR2 CDC20 NFATC3

1.78e-04200374M4124
CoexpressionGSE17580_TREG_VS_TEFF_DN

TSC22D1 CHD7 SLC30A4 RNF111

1.78e-04200374M3671
CoexpressionTABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING

HLA-B HLA-C

2.30e-0416372MM3766
CoexpressionLEE_CALORIE_RESTRICTION_NEOCORTEX_UP

TSC22D1 HLA-B HLA-C

2.53e-0487373MM652
CoexpressionRUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP

HIPK3 HLA-B

2.60e-0417372M1581
CoexpressionAtlasFacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500_k-means-cluster#3

CHD7 NRXN2 HLA-C LARS2

4.65e-05118364Facebase_RNAseq_e8.5_Floor Plate_500_K3
CoexpressionAtlasFacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#2

SPRY1 CHD7 NRXN2 HLA-C LARS2

5.85e-05248365Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K2
CoexpressionAtlasFacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#2

CHD7 NRXN2 LARS2

7.81e-0549363Facebase_RNAseq_e10.5_Medial Nasal Eminence_500_K2
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4

CHD7 NRXN2 HLA-C LARS2

8.80e-05139364Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4
CoexpressionAtlasFacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#2

CHD7 NRXN2 HLA-C LARS2

1.04e-04145364Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500_K2
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4

CHD8 CHD7 NRXN2 HLA-C LARS2

1.39e-04298365Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4
CoexpressionAtlasFacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500_k-means-cluster#4

CHD7 HLA-B LARS2

1.99e-0467363Facebase_RNAseq_e9.5_Facial Mesenchyne_500_K4
ToppCell10x5'-blood-Lymphocytic_Invariant-Inducer-like-MAIT|blood / Manually curated celltypes from each tissue

SPRY1 NEO1 HLA-B ROR2

1.32e-05175374b4e4b66e89f79999768a6192c8404cb2465f920b
ToppCellCV-Severe-7|CV / Virus stimulation, Condition and Cluster

NCOR2 CHD7 HLA-B HLA-C

1.35e-051763743de0c7d77210049e5616db21eed1490a17a5ec2d
ToppCellCV-Severe-7|Severe / Virus stimulation, Condition and Cluster

NCOR2 CHD7 HLA-B HLA-C

1.38e-0517737482fdd6185b368f54f03de389427cbe3071d21a99
ToppCellmetastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass

GRIN2B OLFML1 ROR2 AOC3

1.71e-05187374e04fb35f2f5b120659d06b5ae427ab1ec56d5c36
ToppCellControl-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class

HIPK3 SPRY1 ABL2 AOC3

1.71e-051873745429ae85942b8ec3895cceb63c663de3c24ca064
ToppCellhematopoetic_progenitors-CD34+_CLP|World / Lineage and Cell class

AFF1 SPRY1 TSC22D1 NRXN2

1.86e-0519137432f2537c97c9984629d61c6f34a337f555146ad4
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

GRIN2B HLA-B HLA-C ROR2

1.86e-051913747235a4d1601c88a2c8af571a2c04ab56d32f1b9a
ToppCell3'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SPRY1 TSC22D1 ENTPD3 AOC3

2.06e-0519637488dc4e3efd7ea07617ecde142ec47cc57608f81b
ToppCell(2)_NK/T-(220)_CD8+_Cytotoxic_T_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)

SPRY1 HLA-B HLA-C ROR2

2.06e-05196374d123361c32bcd2329200f0316bc5b54bb494e92d
ToppCellnormal-na-Lymphocytic_NK-T_mait-female|normal / PBMC cell types (v2) per disease, treatment status, and sex

SPRY1 HLA-B HLA-C ROR2

2.10e-051973748752c0f37979aa7bf2e8aee6990fb6307a6666b7
ToppCell(2)_NK/T-(22)_CD8+_T_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)

SPRY1 HLA-B HLA-C ROR2

2.10e-0519737420dad8e4ed36a0185e231ddcb327725d2b2005e0
ToppCell(220)_CD8+_Cytotoxic_T_cell|World / immune cells in Peripheral Blood (logTPM normalization)

SPRY1 HLA-B HLA-C ROR2

2.14e-051983742af389b8ea5767ba56fe64d719afe5be3f9a43ec
ToppCell5'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SPRY1 TSC22D1 ENTPD3 AOC3

2.19e-05199374f1723cfd6fbb8c8903a3b167872ec8523e3be250
ToppCellMS-Multiple_Sclerosis-Lymphocyte-T/NK-MAIT|Multiple_Sclerosis / Disease, condition lineage and cell class

SPRY1 HLA-B HLA-C ROR2

2.23e-0520037410120f474ac3de10fc8e66158969415bd3f8c1da
ToppCellILEUM-non-inflamed-(7)_Endothelial_cell-(7)_CD36+_endothelial_cells|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

SPRY1 TSC22D1 HLA-B HLA-C

2.23e-0520037446dac23d8f9d426fe52ad6dac9c15ce91e615762
ToppCellTransplant_Alveoli_and_parenchyma-Endothelial-Endothelial|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X

TSC22D1 ABL2 HLA-B HLA-C

2.23e-052003742ae62c428728c1d9d4471d4be24bd6ab074fa22c
ToppCellClub_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id

MYO18A CDC20 GGT6

1.35e-041203737f85208f0455f3e634f8e7e81beea60b4ef1d2a5
ToppCell343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

HLA-B HLA-C AOC3

2.08e-041393732fdc8f36510aff24abbc79ef2a842db75a85f946
ToppCell343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

HLA-B HLA-C AOC3

2.08e-041393735970a654c64e3b54f9d18c102f5b125eec892fc5
ToppCellLPS-antiTNF-Epithelial_alveolar-Mes-like-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

GRIN2B CDC20 ANKRD55

2.21e-041423735690eee2ce1ecd02e34eac4193578bd13c4228b9
ToppCellCOVID-19_Mild-PLT_3|World / Disease Group and Platelet Clusters

NEO1 HLA-C GGT6

2.45e-041473739d3271aa735ddb6f32ab864d7afcfb0f8754383b
ToppCellmetastatic_Lymph_Node-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass

HLA-B HLA-C AOC3

2.50e-04148373db046a02a00829910bf9d7dbda068e730aa78f00
ToppCellLPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CDC20 ENTPD3 PPP1R16A

2.65e-04151373c06a54afe918b14f885d6a85fbcf81e80f33afae
ToppCellpdx-Tumor_cells-T4|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

HLA-C GGT6 PTRHD1

2.70e-041523737ccc56b79c499dd48dab8e2d936edca5223b9356
ToppCell390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|390C / Donor, Lineage, Cell class and subclass (all cells)

HLA-B HLA-C RELL2

2.75e-04153373ce7a23c687e9e7d83d244046de19c854caded09b
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW19|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.

SPRY1 TSC22D1 ZC3H13

2.86e-041553739d53caee196b5c2bbc90c4f54f693b64d4086065
ToppCellSmart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_memory_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

HLA-B HLA-C ANKRD55

2.91e-041563736146232d55ef41b1d3c3d7de4d876dcb7fc76f6f
ToppCell10x3'2.3-week_12-13-Myeloid_DC-DC-DC3|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

CDC20 HLA-B HLA-C

3.20e-0416137339030380e04f57f8e7de231577ec3177e1b6490d
ToppCellBAL-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

MYO18A SLC30A4 ANKRD55

3.20e-0416137378cc5bc488bc47726195a649946d414e6bfabf94
ToppCellnormal-na-Lymphocytic_T-T4_reg-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

MYO18A ZNF777 SLC47A2

3.31e-0416337343887e7687fc6367efac0c1f56a9534b06f47b7f
ToppCellBronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

GRIN2B OLFML1 SLC47A2

3.37e-041643733cd80e6275f0f9b5667912139d15ebf5e6b17f2f
ToppCelltumor_Lymph_Node_/_Brain-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass

HLA-B HLA-C PPP1R16A

3.37e-0416437392fb94492fc2b683e9d50a9db6f01d23c194b0e4
ToppCellICU-NoSEP-Lymphocyte-T_NK-MAIT|ICU-NoSEP / Disease, Lineage and Cell Type

SPRY1 ZNF777 SLC30A4

3.49e-04166373d3fa2e42497201f1ca57f4f977fbaa0def950033
ToppCellControl-Lymphocyte-T_NK-MAIT|Control / Disease, Lineage and Cell Type

SPRY1 NEO1 ROR2

3.68e-041693738c2aac193a9c500f01a99a2ee530839c851b6222
ToppCellTransplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X

CDC20 LARS2 GGT6

3.75e-04170373aabe993c9f337b1caaeb0e64626a3920579c41b7
ToppCellTransplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X

CDC20 LARS2 GGT6

3.88e-04172373b66dbfff5e4f53ca8ece91ff9c5dc66a71f07c63
ToppCellMultiple_Sclerosis-Lymphocyte-T_NK-MAIT|Multiple_Sclerosis / Disease, Lineage and Cell Type

SPRY1 HLA-B HLA-C

3.88e-0417237318bda0038cb37da6784e7bf7291272c108cfd9c5
ToppCell390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|390C / Donor, Lineage, Cell class and subclass (all cells)

HLA-B HLA-C RELL2

3.94e-04173373b06d6e7acb7086bb99600b680cf404c0ef06b52c
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HLA-B HLA-C ANKRD55

3.94e-041733730ba64e5385fe714f876002520f8b5202809bf11e
ToppCell(6)_Endothelial_cells-(6)_Endothelial-E|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)

NEO1 HLA-B HLA-C

4.01e-041743734a1b67ce5ea353b3f81f59fa57da07668146afca
ToppCell10x5'-blood-Lymphocytic_Invariant-Inducer-like|blood / Manually curated celltypes from each tissue

SPRY1 NEO1 ROR2

4.01e-0417437351be6f29308c01593978cbee92114151a5916c9c
ToppCellRSV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster

HLA-B HLA-C NFATC3

4.08e-04175373ff3a27f512a3a710ebc863b7b75cce8167d5440b
ToppCellRSV-Healthy-1|RSV / Virus stimulation, Condition and Cluster

HLA-B HLA-C NFATC3

4.08e-04175373ca52b99b03535a5b3a2751d6981708dc5b255b91
ToppCelldroplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CDC20 RELL2 ANKRD55

4.15e-04176373581045e61cdcdfa85701343d1a7c0a72a36606a7
ToppCell3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TSC22D1 ENTPD3 AOC3

4.15e-0417637390f36f10c6ed440a0ca549f23219398853f1fbc3
ToppCellsystemic_lupus_erythematosus-managed-Lymphocytic_NK-T_mait-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

NEO1 HLA-B HLA-C

4.22e-04177373605f71515c877bb4de4121675ec8c1318a2500a7
ToppCell356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells)

SPRY1 OLFML1 AOC3

4.22e-041773737617270f49cd6b7ba66db72d20560cee985012b2
ToppCell356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells)

SPRY1 OLFML1 AOC3

4.22e-041773738220cc2fc0ee8764a67a3be51d75248be2453040
ToppCell3'-GW_trimst-1-SmallIntestine-Hematopoietic-B_cells-Pre-B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

MYO18A HLA-B HLA-C

4.22e-04177373ecd26d086c1aff3be442fcb055611a563ca034ef
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CHD7 ANKRD55 ENTPD3

4.36e-04179373cd7f0e8f4abb2a2bac366c8910c8c5fda841dbce
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

AFF1 GRIN2B ROR2

4.43e-04180373023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5
ToppCellBronchial_Biopsy-Mesenchymal-Smooth_muscle|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X

NRXN2 OLFML1 AOC3

4.43e-041803737085a851807e6a833965e1366946db0bbc5174e2
ToppCellwk_08-11-Mesenchymal-Fibroblast-Mesenchymal_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

TSC22D1 GRIN2B HLA-B

4.50e-041813737e3bcfa2ba5b98a7df5854aa6e7a31e9a71faa8a
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HLA-B HLA-C ANKRD55

4.65e-04183373e3ffef2b57dc5b96466dccc9cd54ba326ccf378a
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_memory_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

HLA-B HLA-C ANKRD55

4.65e-04183373aa66149363bb0b6fe1b6044aa2001ace0e4f717e
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9

HIPK3 ABL2 NFATC3

4.72e-0418437367164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCelldroplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SPRY1 OLFML1 ROR2

4.79e-04185373355b03c7ea438681e11a2b872c798c9ea26e1486
ToppCellTCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9

ABL2 OLFML1 AOC3

4.87e-041863731e6526fc9e9381b7ace864588cc7bd80194338d6
ToppCellfacs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CHD7 NRXN2 LARS2

4.87e-04186373a1ab273b01971d6a892912560d387685dd657179
ToppCell343B-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

TSC22D1 HLA-B HLA-C

4.87e-04186373080e56113b89138277a2bd2eabddfa6cd1a18b61
ToppCell343B-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

TSC22D1 HLA-B HLA-C

4.87e-04186373dae6a98963c78bf7518ebab8dc02f173c3b0f7f7
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

OLFML1 ROR2 AOC3

4.87e-041863735473283fb95cee556b1f6934cf72169b676b5bcc
ToppCellE12.5-Epithelial-epithelial_progenitor_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

SPRY1 CHD7 ENTPD3

4.95e-04187373ab6f4d387218b4651fdadbf269806c1ddc96a1d2
ToppCellE12.5-Epithelial|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

SPRY1 CHD7 ENTPD3

4.95e-0418737329ea5e14dac3321df76f6aa4f053068b49c4a4bf
ToppCellfacs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CHD7 NRXN2 LARS2

4.95e-04187373ef3c85c01bc3da408ae288b6e3096ad888a12e63
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SPRY1 NEO1 ROR2

4.95e-04187373f1ba41f2ec703251a81c46e08d45e70210f298e7
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

AFF1 GRIN2B ROR2

4.95e-04187373e3095455d2f255854f339f6b05fa87852af0700f
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NRXN2 OLFML1 ROR2

5.02e-04188373e18065bbc26d6f3774fd1f478fb41d8fb555fa26
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HLA-B HLA-C ANKRD55

5.02e-041883730501a8aa850bd2e347020abd1cac4d8075738189
ToppCellcritical-Epithelial-IRC-IFNG_responsive_cell|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

GRIN2B HLA-B HLA-C

5.02e-04188373023f6e34c2db8657d25e70a97b7b9d45166c13ad
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

AFF1 GRIN2B ROR2

5.10e-041893733a295c215b5c18e7c673f92b7af5be523421682c
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

AFF1 GRIN2B ROR2

5.10e-04189373c9565e962a13a7713056ec3dbb1b67d24f9889c7
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANKRD55 ROR2 ENTPD3

5.10e-04189373979b7fa947538aa7ca4a219263da2575869a2caa
ToppCell10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-MAIT|lymph-node_spleen / Manually curated celltypes from each tissue

SPRY1 HLA-B HLA-C

5.10e-04189373afe3a4fe7c10eeeb7064129778d940269c9acbef
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

AFF1 GRIN2B ROR2

5.18e-0419037311d3c31167ea71809b4cc3757a0c6ea54a448602
ToppCellSevere-MAIT|World / Disease group and Cell class

SPRY1 CHD7 HLA-C

5.18e-041903737a92e0d6a021be23125495927b8571e25c83204a
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

SPRY1 NEO1 ROR2

5.18e-0419037305e6af222d0ad97cb69f399a96c9038f9dd989b9
ToppCellhematopoetic_progenitors-CD34+_CLP|hematopoetic_progenitors / Lineage and Cell class

AFF1 SPRY1 NRXN2

5.18e-04190373117abdafd294c85ccb5d8ea907e3c0491b7200b2
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

AFF1 GRIN2B ROR2

5.18e-04190373b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84
ToppCellkidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

AFF1 GRIN2B ROR2

5.18e-04190373078f4be52fa4cc8dd9c8d7a2b6d9631c3d902285
ToppCellSevere-MAIT|Severe / Disease group and Cell class

SPRY1 CHD7 HLA-C

5.18e-041903731c063dc1b62d9f9912aaf8d0297555a6545f5550
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

NEO1 GRIN2B OLFML1

5.26e-04191373156b467187331ac6ca390d6ca861d9670bb7b956
ToppCellfacs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SPRY1 NRXN2 OLFML1

5.26e-041913735c4e4e9de14edfae072a2a2882220a31bebf51b2
ToppCell5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-MMP9+_Inflammatory_macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HLA-B HLA-C SDHD

5.26e-0419137387b974a320888d63aa8cefcd8dc97d525b56d848
ToppCellControl-Lymphoid-T_Cytotoxic|Lymphoid / Disease state, Lineage and Cell class

SPRY1 HLA-B HLA-C

5.26e-04191373ff7204f9b645233548cf804cf6fe0c86417be87f
ToppCellfacs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SPRY1 NRXN2 OLFML1

5.26e-0419137380484d39f34703a33b9bac09826b7a526e883cab
ToppCellILEUM-inflamed-(1)_T_cell-(1)_Th17_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

SPRY1 HLA-B HLA-C

5.34e-0419237312f7ea575da5d650c740e6060f5dab0478e563dd
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANKRD55 ROR2 ENTPD3

5.34e-04192373bd3fa6c8fcb618db64d11f25cabaf08608957c35
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANKRD55 ROR2 ENTPD3

5.34e-04192373f6ec683b2133b3095a1fcc06ca8605cf38f774b5
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANKRD55 ROR2 ENTPD3

5.34e-04192373690b3d17c481159bc96b8bc7f6a66b51343ee858
ToppCell3'-Child09-12-SmallIntestine-Mesenchymal-Pericytes|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TSC22D1 ENTPD3 AOC3

5.34e-041923737aadc7c5bd03274f9861dde2febda5c37f8afc9c
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ANKRD55 ROR2 ENTPD3

5.34e-0419237363d1b3efe93e5ff939278ebe40bacb38218ea09b
ToppCellILEUM-non-inflamed-(1)_Th17_Trm|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

SPRY1 HLA-B HLA-C

5.34e-041923737347ff4dedd1aaa489c4f15e5ae647a4ce39ac72
ToppCellILEUM-inflamed-(1)_T_cell-(1)_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

SPRY1 CHD7 HLA-B

5.34e-041923739a2560921b8c0997e1788053004f099439e8f071
ToppCellBrain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-IPC_like|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.

CHD7 HLA-B HLA-C

5.42e-04193373f24bae40f5cbcfece04fbefe4e3de1b88ac90de4
ToppCell367C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

NEO1 HLA-B HLA-C

5.42e-041933735c6b03d6d98aa873fda1a201d44a912246bb5a92
ToppCellfacs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AFF1 LARS2 NFATC3

5.42e-04193373a6a864644e1b80b7417ea0a27281e79068a3fd3d
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

NRXN2 OLFML1 ROR2

5.42e-04193373b05361ffe111a38cfa26eb86e4ae62c15ac99b7b
ToppCellPosterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

GRIN2B RELL2 ZC3H13

5.42e-04193373b4989e3436e84dbec3789b46057e0f7a0ebf09d4
ToppCell367C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

NEO1 HLA-B HLA-C

5.42e-04193373d4b58eee97043b4337ec36c40f9af6499d864df9
ComputationalGenes upregulated in subsets of cells of a given type within various tumors

TSC22D1 HLA-B HLA-C

1.79e-0450243GAVISH_3CA_METAPROGRAM_EPITHELIAL_INTERFERON_MHC
ComputationalGenes in the cancer module 293.

HLA-B HLA-C

3.11e-0412242MODULE_293
ComputationalGenes in the cancer module 143.

HLA-B HLA-C

4.28e-0414242MODULE_143
DiseaseAutism Spectrum Disorders

CHD8 SIN3A GRIN2B NRXN2

2.46e-0685334C1510586
Diseaseallergic asthma (is_implicated_in)

HLA-B HLA-C

1.21e-055332DOID:9415 (is_implicated_in)
Diseasedevelopmental disorder of mental health (implicated_via_orthology)

NCOR2 SIN3A GRIN2B

2.27e-0549333DOID:0060037 (implicated_via_orthology)
DiseaseCHARGE syndrome (implicated_via_orthology)

CHD8 CHD7

2.54e-057332DOID:0050834 (implicated_via_orthology)
Diseasegraft-versus-host disease (implicated_via_orthology)

HLA-B HLA-C

2.54e-057332DOID:0081267 (implicated_via_orthology)
Diseasebeta-2 microglobulin measurement

HLA-B HLA-C

6.63e-0511332EFO_0005197
Diseasetriglycerides:total lipids ratio, high density lipoprotein cholesterol measurement

AFF1 NCOR2 HLA-B HLA-C

8.06e-05206334EFO_0004612, EFO_0020947
Diseaseegg allergy measurement, parental genotype effect measurement

GRIN2B ANKRD55

9.39e-0513332EFO_0005939, EFO_0007018
Diseasefree cholesterol measurement, very low density lipoprotein cholesterol measurement

AFF1 NCOR2 HLA-B RNF111

9.50e-05215334EFO_0008317, EFO_0008591
Diseasevery low density lipoprotein cholesterol measurement, lipid measurement

AFF1 NCOR2 HLA-B RNF111

1.04e-04220334EFO_0004529, EFO_0008317
Diseasetotal cholesterol measurement, very low density lipoprotein cholesterol measurement

AFF1 NCOR2 HLA-B RNF111

1.11e-04224334EFO_0004574, EFO_0008317
Diseasecholesteryl ester measurement, very low density lipoprotein cholesterol measurement

AFF1 NCOR2 HLA-B RNF111

1.13e-04225334EFO_0008317, EFO_0010351
Diseasevery low density lipoprotein cholesterol measurement, phospholipid measurement

AFF1 NCOR2 HLA-B RNF111

1.21e-04229334EFO_0004639, EFO_0008317
Diseasekiller cell immunoglobulin-like receptor 2DS2 measurement

HLA-B HLA-C

1.26e-0415332EFO_0801746
DiseaseIntellectual Disability

CHD8 SIN3A GRIN2B NRXN2 PTRHD1

1.30e-04447335C3714756
Diseasevery low density lipoprotein cholesterol measurement

AFF1 NCOR2 HLA-B RNF111

1.97e-04260334EFO_0008317
DiseaseCOVID-19 (is_implicated_in)

HLA-B HLA-C

2.51e-0421332DOID:0080600 (is_implicated_in)
DiseasePrecursor B-cell lymphoblastic leukemia

AFF1 HLA-C

2.51e-0421332C1292769
Diseasefumarate measurement

LARS2 PPP1R16A

2.51e-0421332EFO_0010480
Diseaselymphocyte measurement

HLA-B HLA-C NFATC3

3.04e-04117333EFO_0803546
Diseasephospholipids:total lipids ratio, high density lipoprotein cholesterol measurement

AFF1 NCOR2 HLA-B HLA-C

3.71e-04307334EFO_0004612, EFO_0020946
DiseaseDrug-Induced Stevens Johnson Syndrome

HLA-B HLA-C

4.83e-0429332C1274933
DiseaseToxic Epidermal Necrolysis

HLA-B HLA-C

4.83e-0429332C0014518
DiseaseMycoplasma-Induced Stevens-Johnson Syndrome

HLA-B HLA-C

4.83e-0429332C3658301
DiseaseStevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum

HLA-B HLA-C

4.83e-0429332C3658302
DiseaseMental Retardation, Psychosocial

CHD8 SIN3A GRIN2B

5.03e-04139333C0025363
DiseaseProfound Mental Retardation

CHD8 SIN3A GRIN2B

5.03e-04139333C0020796
DiseaseMental deficiency

CHD8 SIN3A GRIN2B

5.03e-04139333C0917816
DiseaseStevens-Johnson Syndrome

HLA-B HLA-C

5.17e-0430332C0038325
Diseaseseasonal allergic rhinitis

ABL2 HLA-B

5.89e-0432332EFO_0003956
Diseaseautism spectrum disorder (implicated_via_orthology)

CHD8 CHD7 NRXN2

6.53e-04152333DOID:0060041 (implicated_via_orthology)
Diseaseserum non-albumin protein measurement

AFF1 NCOR2 HLA-B ANKRD55

6.81e-04361334EFO_0004568
DiseaseBurkitt Lymphoma

AFF1 HLA-C

7.46e-0436332C0006413
Diseasehuman immunodeficiency virus infectious disease (is_implicated_in)

HLA-B HLA-C

8.76e-0439332DOID:526 (is_implicated_in)

Protein segments in the cluster

PeptideGeneStartEntry
THTGMHTLTGTHVHT

nan

86

Q6ZRP5
HTLTGTHVHTPHTQM

nan

91

Q6ZRP5
LSSGSRSGHIHHHDV

CDC20

281

Q12834
PSSPHVDSSTMLHHH

CHD8

2481

Q9HCK8
HHHSTVADGLVTTLH

ABL2

246

P42684
HRATSHAGLSSAPHH

ANKRD55

451

Q3KP44
VQHIHLSPSHHSGSK

SDHD

46

O14521
LSPSHHSGSKAASLH

SDHD

51

O14521
FHHHPSTALHGESVA

CHD7

256

Q9P2D1
VSEHTLGTVHTHSAH

AOC3

511

Q16853
SHLHGSTPIHLGATA

ENTPD3

126

O75355
SRPASHSHAHQHSPI

NCOR2

1846

Q9Y618
THVTHHPLSDHEATL

HLA-C

211

P10321
SSKPHHFLLGHSHGT

MYO18A

921

Q92614
TLSHGSPNHTAVHAH

HIPK3

1091

Q9H422
THVTHHPISDHEATL

HLA-B

211

P01889
AIHSGPGTHSHLVLT

OLFML1

281

Q6UWY5
ARVSSSLSTTHHVHH

NRXN2

51

P58401
SAPHLTHHTLHNIHG

QTRT2

41

Q9H974
VAAHTEHAHVSSVPH

GGT6

471

Q6P531
TGHIRPRTHTHTGTH

FAM27E3

61

Q08E93
AHLTSHIHNHLPTQG

PRDM4

561

Q9UKN5
SSLQDGAPSHHHTVH

RELL2

111

Q8NC24
GAPSHHHTVHLGSAA

RELL2

116

Q8NC24
TAALHTHRDHPHTAA

PTRHD1

56

Q6GMV3
ILHPSHSHLSRASFH

SLC47A2

196

Q86VL8
HVAISPSHRLLHGHS

LARS2

311

Q15031
PHHHFHSSSLASPAR

NEO1

1261

Q92859
STTPHTLVHDKAHHT

PPP1R16A

441

Q96I34
PAIAAVHSSHHHPTA

SIN3A

76

Q96ST3
ALQHPHSHHLSSTDF

ROR2

341

Q01974
HHHPSHVAVASASIT

TSC22D1

236

Q15714
AALTSHPHHAVHQGL

POU4F3

101

Q15319
SFHTSVHHQSIHTPA

AFF1

106

P51825
PHPVHAFHSQISSHA

RNF111

686

Q6ZNA4
STGHLLAHTPHSVHT

NFATC3

861

Q12968
HRHTSHLGHAVLPSN

SPRY1

91

O43609
LNQSGHRHSHSHSLP

SLC30A4

236

O14863
SLLSHSPHHQEAPVH

ZNF777

116

Q9ULD5
GQHHSPISSRHHSSS

ZC3H13

321

Q5T200
HHHHRPHSIGSASSI

GRIN2B

986

Q13224